![]() Dr Lal PathLabs Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests. | ![]() Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases. | ![]() Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | ||
Founding Date | Founding Date 1949 | Founding Date 1967 | Founding Date 2011 | Founding Date 2004 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Gurugram, IN HQ | Locations Secaucus, US HQ São Paulo, BR Hyderabad, IN Dublin, IE Ciudad De México, MX | Locations Seattle, US HQ | Locations Melbourne, AU HQ Singapore, SG New York, US |
Employees | Employees 4,099 | Employees 46,00018% decrease | Employees 27 | Employees 73 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 17.4 b | Valuation ($) N/A | Valuation ($) 1.2 b |
Financial | ||||
Revenue (est.) | Revenue (est.) ₹27.6b (FY, 2026) | Revenue (est.) $11b (FY, 2025) | Revenue (est.) $6.1m (FY, 2022) | Revenue (est.) $17.2m (FY, 2025) |
Cost of goods | Cost of goods ₹5.3b (FY, 2026) | Cost of goods $7.4b (FY, 2025) | Cost of goods N/A | Cost of goods $1.2m (FY, 2025) |
Gross profit | Gross profit ₹23.3b (FY, 2026) | Gross profit $3.7b (FY, 2025) | Gross profit N/A | Gross profit $16.1m (FY, 2025) |
Net income | Net income ₹5.1b (FY, 2026) | Net income $1b (FY, 2025) | Net income ($187.9m) (FY, 2022) | Net income ($102.1m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 171m | Total funding raised $ 56.2m |
Quest Diagnostics is a company that provides diagnostic information solutions.
View company
Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.
View company
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View company